PER 1.35% 7.5¢ percheron therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-54

  1. 2,956 Posts.
    lightbulb Created with Sketch. 116

    It is hard to gauge what is currently occurring behind the scenes. I can only assume (one never should) that if results were not favourable this would be known and communicated to the market by now.

    Given there is ‘patent’ discussions in the last report I can only take from this that ANP as an organisation must secure their findings/IP.

    If this is in fact the case than a delay on an announcement would make sense and given this detail was in the last report (Quarterly) would be a cryptic message for shareholders to perhaps read between the lines and hang tight.

    Again, an assumption.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
0.001(1.35%)
Mkt cap ! $67.61M
Open High Low Value Volume
7.7¢ 7.8¢ 7.4¢ $24.63K 325.4K

Buyers (Bids)

No. Vol. Price($)
2 142779 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8181 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.